10:14 AM EST - Medicenna Therapeutics Corp. : Presented a poster entitled "MDNA55: A Locally Administered IL4 Guided Toxin as a Targeted Treatment for Recurrent Glioblastoma" at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held in Chicago. Medicenna Therapeutics Corp.
shares T.MDNA are trading down $0.01 at $0.83.
